SNSP-113

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameSNSP-113
Drug Alias Namepoly (acetyl, arginyl) glucosamine (PAAG15A)SYGN-113SNSP-113MIIST-113PAAG-15A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall modulatorsCell adhesion molecules inhibitors
TargetsCell adhesion molecules
Therapy Area/IndicationsLung DiseasesRespiratory Tract DiseasesCystic Fibrosis +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSynspira Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSynspira Inc
Active IndicationsN/A
Inactive IndicationsLung DiseasesRespiratory Tract DiseasesCystic Fibrosis +[8] 

Other Information

ATC CodeN/A
Related LinksN/A